Northeast Investment Management Gilead Sciences, Inc. Transaction History

Northeast Investment Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$57.92 - $72.58 $184,359 - $231,022	-3,183 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $6,552 - $7,437	-101 Reduced 3.08%	3,183 $231,000
Q3 2021 Nov 08, 2021	BUY	$67.69 - $73.03 $222,293 - $239,830	3,284 New	3,284 $229,000
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $289,651 - $330,044	-5,113 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $34,838 - $43,802	561 Added 12.32%	5,113 $323,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $329,291 - $382,368	4,552 New	4,552 $350,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $182,830 - $238,580	-3,020 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $101,431 - $112,303	-1,423 Reduced 32.03%	3,020 $233,000
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $11,483 - $13,395	-177 Reduced 3.83%	4,443 $315,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $29,136 - $35,520	-400 Reduced 7.97%	4,620 $348,000
Q4 2017 Jan 29, 2018	SELL	$71.15 - $83.52 $89,791 - $105,402	-1,262 Reduced 20.09%	5,020 $360,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $452,995 - $536,922	6,282	6,282 $509,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

Stay updated on Northeast Investment Management with notifications on news.